Results 61 to 70 of about 2,093 (92)

The utility of CXCL13 and circulating CXCR5⁺ T cell detection in the diagnosis of systemic lupus erythematosus associated nephritis. [PDF]

Front Immunol
Liu Y, Tan SY, Huang MK, Yang YL, Hui L, Liu T.   +5 more
europepmc   +1 more source

[<i>Streptococcus salivarius</i>-derived extracellular vesicles exacerbate progression of lupus nephritis by activating natural killer cells]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Xiao J, Jin L, Duan L, Gong Y, Li H.
europepmc   +1 more source

Engineered exosomes conferred with ROS-regulation and immuno-suppression for ameliorating lupus nephritis. [PDF]

J Nanobiotechnology
Tian J, Wang Z, Tang Z, Zhu H, Sun L.
europepmc   +1 more source

Effects of environmentally-induced anxiety on autoimmunity in the MRL/lpr mouse. [PDF]

Lupus Sci Med
Zhang F, Zhang Q, Dang RN, Tian XX, Li LJ, Zhou QM, Li XY, Wu YS, Zou HM.   +8 more
europepmc   +1 more source

Anti-C1q Autoantibody-Binding Engineered scFv C1q-Mimicking Fragment Enhances Disease Progression in Lupus-Prone MRL/lpr Mice. [PDF]

Int J Mol Sci
Bradyanova S, Mihaylova N, Ralchev N, Kapogianni A, Cholakova G, Nikolova-Ganeva K, Tsacheva I, Tchorbanov A.   +7 more
europepmc   +1 more source

MiR-1290 in natural killer cell derived extracellular vesicles: a pathogenic mediator of lupus nephritis and therapeutic target for th17 regulation. [PDF]

J Nanobiotechnology
Cheng C, Su H, Li X, Li R, Yang Q, Guan T, Li M, Ou C.   +7 more
europepmc   +1 more source

Lang-chuang-ding restores bone homeostasis in systemic lupus erythematosus associated osteoporosis by targeting NF-κB signaling: a network pharmacology and experimental study. [PDF]

Front Endocrinol (Lausanne)
Luo H, Zhou H, Shen S, Zeng L, Ruan H.
europepmc   +1 more source

Mediterranean fever gene variants may prevent the development of lupus nephritis in Japanese patients with systemic lupus erythematosus. [PDF]

Front Immunol
Endo Y, Koga T, Mohamed L, Tsuji Y, Umeda M, Hayashi H, Kishino T, Kawakami A.   +7 more
europepmc   +1 more source

Withaferin A, a candidate drug for lupus nephritis, confers renal protection via Pon1‑mediated attenuation of oxidative stress. [PDF]

Int J Mol Med
Xue M, Feng J, Mao X.
europepmc   +1 more source

Design and development of a bispecific antibody targeting BAFF and IL-17 for systemic lupus erythematosus treatment. [PDF]

BMC Biol
Xin C, Zhou J, Chen Y, Liu Y, Liu H, Liang C, Zhu X, Qi Y, Zhang G, Wang A.   +9 more
europepmc   +1 more source